Literature DB >> 15610029

Phosphoregulation of mixed-lineage kinase 1 activity by multiple phosphorylation in the activation loop.

John T Durkin1, Beverly P Holskin, Karla K Kopec, Matt S Reed, Chrysanthe M Spais, Brian M Steffy, George Gessner, Thelma S Angeles, Jan Pohl, Mark A Ator, Sheryl L Meyer.   

Abstract

Mixed-lineage kinase 1 (MLK1) is a mitogen-activated protein kinase kinase kinase capable of activating the c-Jun NH(2)-terminal kinase (JNK) pathway. Full-length MLK1 has 1104 amino acids and a domain structure identical to MLK2 and MLK3. Immunoblot and mass spectrometry show that MLK1 is threonine (and possibly serine) phosphorylated in or near the activation loop. A kinase-dead mutant is not, consistent with autophosphorylation. Mutation to alanine of any of the four serine or threonine residues in the activation loop reduces both the activity of the recombinant kinase domain and JNK pathway activation driven by full-length MLK1 expressed in mammalian cells. Furthermore, the gel mobility of the mutant MLK1s is closer to that of the kinase-dead than wild type, consistent with reduced phosphorylation. Thr312 is the key residue: MLK1[T312A] retains only basal activity (about 1-2% of wild type), and its gel mobility is indistinguishable from kinase-dead. Thr312 does not suffice, however; phosphorylation of multiple sites is necessary for full activation of MLK1. An activation mechanism consistent with these data involves phosphorylation of multiple sites in the activation loop, with phosphorylation of Thr312 required for full phosphorylation. This mechanism is broadly similar to that previously reported for MLK3 [Leung, I. W., and Lassam, N. (2001) J. Biol. Chem. 276, 1961-1967], but the key residue differs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610029     DOI: 10.1021/bi049866y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Regulation of mixed-lineage kinase activation in JNK-dependent morphogenesis.

Authors:  Rebecca A Garlena; Rebecca L Gonda; Alyssa B Green; Rachel M Pileggi; Beth Stronach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

Review 2.  Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity?

Authors:  Matthew E Handley; Jane Rasaiyaah; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2007-04       Impact factor: 1.925

3.  Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing.

Authors:  Mitchell S Stark; Susan L Woods; Michael G Gartside; Vanessa F Bonazzi; Ken Dutton-Regester; Lauren G Aoude; Donald Chow; Chris Sereduk; Natalie M Niemi; Nanyun Tang; Jonathan J Ellis; Jeffrey Reid; Victoria Zismann; Sonika Tyagi; Donna Muzny; Irene Newsham; YuanQing Wu; Jane M Palmer; Thomas Pollak; David Youngkin; Bradford R Brooks; Catherine Lanagan; Christopher W Schmidt; Bostjan Kobe; Jeffrey P MacKeigan; Hongwei Yin; Kevin M Brown; Richard Gibbs; Jeffrey Trent; Nicholas K Hayward
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

Review 4.  The regulatory function of mixed lineage kinase 3 in tumor and host immunity.

Authors:  Sandeep Kumar; Sunil Kumar Singh; Basabi Rana; Ajay Rana
Journal:  Pharmacol Ther       Date:  2020-10-09       Impact factor: 13.400

5.  Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+1 loop.

Authors:  Mathias Cobbaut; Rita Derua; Heike Döppler; Hua Jane Lou; Sandy Vandoninck; Peter Storz; Benjamin E Turk; Thomas Seufferlein; Etienne Waelkens; Veerle Janssens; Johan Van Lint
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

Review 6.  Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma.

Authors:  Yoshiaki Yura; Atsushi Masui; Masakazu Hamada
Journal:  Cancers (Basel)       Date:  2020-07-26       Impact factor: 6.639

7.  Machine learning compensates fold-change method and highlights oxidative phosphorylation in the brain transcriptome of Alzheimer's disease.

Authors:  Jack Cheng; Hsin-Ping Liu; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

8.  MicroRNA-148b enhances proliferation and apoptosis in human renal cancer cells via directly targeting MAP3K9.

Authors:  Fang Nie; Tianming Liu; Liang Zhong; Xianggui Yang; Yunhong Liu; Hongwei Xia; Xiaoqiang Liu; Xiaoyan Wang; Zhicheng Liu; Li Zhou; Zhaomin Mao; Qin Zhou; Tingmei Chen
Journal:  Mol Med Rep       Date:  2015-11-11       Impact factor: 2.952

9.  Regulatory roles of conserved phosphorylation sites in the activation T-loop of the MAP kinase ERK1.

Authors:  Shenshen Lai; Steven Pelech
Journal:  Mol Biol Cell       Date:  2016-01-28       Impact factor: 4.138

10.  An evolutionarily conserved mechanism for cAMP elicited axonal regeneration involves direct activation of the dual leucine zipper kinase DLK.

Authors:  Yan Hao; Erin Frey; Choya Yoon; Hetty Wong; Douglas Nestorovski; Lawrence B Holzman; Roman J Giger; Aaron DiAntonio; Catherine Collins
Journal:  Elife       Date:  2016-06-07       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.